Fellowship Training Program

The Division of Pediatric Hematology, Oncology, Stem Cell Transplant & Regenerative Medicine at Stanford unequivocally stands for racial justice and acknowledges structural/societal barriers that have historically disadvantaged people of color in academia and medicine. We define underrepresented in medicine (URM) broadly to include race/ethnicity, sexual orientation, gender identity, socioeconomic status, neurodivergence, and abilities. Our aim is to recruit culturally competent and conscientious providers who perpetuate our guiding principles of inclusion and disparities reduction.

GME Programs to Support Diversity

The Stanford Medicine LEAD (Leadership Education in Advancing Diversity) Program is a 10-month longitudinal leadership program for residents and fellows across GME to develop leadership and scholarship skills in addressing issues related to equity, diversity, and inclusion (EDI), to produce leaders in academic medicine dedicated to EDI, and to improve the culture of medicine.

For more information, click here. 

Department of Pediatrics

The Office of Diversity, Equity, Inclusion, and Justice (DEIJ) hosts a variety of training and educational opportunities in collaboration with the Office of Pediatric Education to create a culture of continuous reflection, learning, and action.  

Stanford University’s Pediatric Stem Transplantation & Cellular Therapy (SCT & CCT) Fellowship Program is seeking applicants for the 2023-24 academic year. All applicants should have completed an ACGME accredited Pediatric Hematology/Oncology fellowship program by the start of our program, being board eligible or board certified. Applicants may apply to one of the following tracks:

• The Stem Cell Transplantation (SCT) track will be a combination of both clinical and research (clinical or basic science).  This tract will allow physicians to obtain FACT certification and be independent providers in cellular therapies. (One fellow)
•  The Cellular Therapy (CCT) track will have an emphasis on the clinical training for patients receiving CAR T cell therapy. Fellows will receive training in the management of not only commercialized CAR T cell products, but also in the development of new investigator-initiated CAR T cell therapies. (One fellow)

This program is proud to serve as a leader in the field of SCT & CCT and works hard to maintain high levels of quality and service that patients have come to expect. Faculty have extensive knowledge and connections within the cellular therapy SCT community and are involved with cutting edge research nationally and internationally.  Close collaboration with faculty in Pediatric SCT & CCT who have diverse clinical, translational and basic research interests, high patient volumes, exposure to novel cell-, gene-, and immune-based therapeutic strategies, and a close collaboration with an internationally recognized Pediatric Hem/Onc, SCT, and CCT center will prepare the fellow for a successful career in the field. The one-year program is designed to provide an incomparable, well-rounded training experience while allowing for flexibility to address the fellow’s specific goals.

The Stanford University Pediatric department has a dedicated interest in developing diversity, equity, and inclusion in their programs. All faculty and staff are encouraged to participate in DEI work, with interviewing faculty taking bias training before recruitment season.

For more information on the Pediatric SCT & CCT program, please reach out to Gretchen Shawver (gshawver@stanford.edu), Program Coordinator, and visit our website:  Stanford Pediatric SCT/CCT 4th Year Fellowship Program